Passage Bio, Inc. (NASDAQ:PASG) Q1 2021 Earnings Conference Call May 5, 2021 8:30 AM ET Company Participants Stuart Henderson - Vice President of Investor Relations and Strategic Finance Bruce Goldsmith - President and Chief Executive Officer Richard Morris - Chief Financial Officer Eliseo Salinas - Chief Research and Development Officer Gary Romano - Chief Medical Officer Jill Quigley - Chief Operating Officer Conference Call Participants Anupam Rama - JPMorgan Chase & Co. Salveen Richter - Goldman Sachs Y ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39231 PASSAGE BIO, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 82- ...

Passage Bio, Inc. (NASDAQ:PASG) Q4 2020 Earnings Conference Call March 3, 2021 8:30 AM ET Company Participants Stuart Henderson - Vice President of Investor Relations and Strategic Finance Bruce Goldsmith - President and Chief Executive Officer Rich Morris - Chief Financial Officer Gary Romano - Chief Medical Officer Jill Quigley - Chief Operating Officer Conference Call Participants Anupam Rama - JP Morgan Salveen Richter - Goldman Sachs Neena Bitritto-Garg - Citi Gbola Amusa - Chardan Laura Chico - Wedbus ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number 001-39231 PASSAGE BIO, INC. (Exact Name of Registrant as Specified in Its Charter) (State or other jurisdiction of (I.R ...

Fulfilling the Promise of Gene Therapies for Central Nervous System Disorders 39th Annual J.P. Morgan Healthcare Conference Bruce Goldsmith, PhD | CEO NASDAQ GS: PASG January 11, 2021 Forward-Looking Statement This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our pl ...

Passage Bio Corporate Presentation NOVEMBER 2020 Forward-Looking Statements This presentation includes "forward-looking statements" within the meaning of, and made pursuant to the safe harbor provisions of, the Private Securities Litigation Reform Act of 1995, including, but not limited to: our expectation about timing and execution of anticipated milestones, including our planned IND submissions and initiation of clinical trials; our expectations about our collaborators' and partners' ability to execute ke ...

Passage Bio, Inc. (NASDAQ:PASG) Q3 2020 Earnings Conference Call November 10, 2020 8:30 AM ET Company Participants Zoe Mita - IR, Stern Investor Relations, Inc. Bruce Goldsmith - President and Chief Executive Officer Rich Morris - Chief Financial Officer Jill Quigley - Chief Operating Officer Gary Romano - Chief Medical Officer Conference Call Participants Anupam Rana - JPMorgan Sonia Gupta - Goldman Sachs Brendan Smith - Cowen and Company Operator Thank you for holding. Good morning and welcome to the Pass ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39231 PASSAGE BIO, INC. (Exact Name of Registrant as Specified in its Charter) Delaware ...

Passage Bio, Inc. (NASDAQ:PASG) Q2 2020 Earnings Conference Call August 13, 2020 8:30 AM ET Company Participants Zoe Mita - IR, Stern Investor Relations, Inc. Jill Quigley - COO Bruce Goldsmith - President and CEO Rich Morris - CFO Gary Romano - Chief Medical Officer Conference Call Participants Anupam Rana - JPMorgan Andrea Tan - Goldman Sachs Yaron Werber - Cowen Operator Thank you for holding. Good morning and welcome to the Passage Bio Second Quarter 2020 Financial and Operating Results Conference Call. ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ⌧ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2020 OR ◻ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ________ to ________ Commission File Number: 001-39231 PASSAGE BIO, INC. (Exact Name of Registrant as Specified in its Charter) Delaware 82-2 ...